Journal list menu
IssueCancer Communications: Volume 40, Issue 12
i, 647-751December 2020
Export Citations
Download PDFs
COVER IMAGE
Front Cover: ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin-3 and NRXN3
- Page: i
- First Published: 16 December 2020
The cover image is based on the Original Article ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin-3 and NRXN3 by Yin Zhao et al., https://doi.org/10.1002/cac2.12104.
ISSUE INFORMATION
EDITORIAL
Abscopal effect of stereotactic radiotherapy combined with anti-PD-1/PD-L1 immunotherapy: Mechanisms, clinical efficacy, and issues
- Pages: 649-654
- First Published: 10 November 2020
REVIEWS
Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges
- Pages: 655-680
- First Published: 03 November 2020
Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine
- Pages: 681-693
- First Published: 08 December 2020
ORIGINAL ARTICLES
Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma
- Pages: 694-710
- First Published: 05 October 2020
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma
- Pages: 711-720
- First Published: 12 December 2020
ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin-3 and NRXN3
- Pages: 721-737
- First Published: 10 October 2020
LETTERS TO THE EDITOR
Mutational characteristics determined using circulating tumor DNA analysis in triple-negative breast cancer patients with distant metastasis
- Pages: 738-742
- First Published: 03 October 2020
Atezolizumab plus bevacizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a cost-effectiveness analysis
- Pages: 743-745
- First Published: 07 November 2020
CASE REPORT
Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide-induced high tumor mutational burden
- Pages: 746-751
- First Published: 23 November 2020
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)